CLINICAL TRIALS PROFILE FOR IMVEXXY
✉ Email this page to a colleague
All Clinical Trials for imvexxy
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05457972 ↗ | Postpartum Vaginal Estrogen | Not yet recruiting | University Hospitals Cleveland Medical Center | Phase 4 | 2022-08-01 | Sexual dysfunction is very common in the postpartum period and is more common in people who breastfeed or pump. This research study was designed to help determine whether postpartum patients who use vaginal estrogen cream while breastfeeding have improved sexual function compared to postpartum patients who do not. |
NCT05617820 ↗ | Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy | Not yet recruiting | Teva Pharmaceuticals USA | Phase 3 | 2022-11-08 | Randomized, double-blind, placebo-controlled, parallel-designed, multiple-site, bioequivalence study with clinical endpoints. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for imvexxy
Condition Name
Clinical Trial Locations for imvexxy
Trials by Country
Clinical Trial Progress for imvexxy
Clinical Trial Phase
Clinical Trial Sponsors for imvexxy
Sponsor Name